Brief: Ultimovacs Q2 Oper Loss Narrows To NOK 35.4 Mln
Aug 19 (Reuters) - Ultimovacs ASA ULTI.OL :
* REG-ULTIMOVACS ASA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES GENERAL BUSINESS UPDATE
* Q2 TOTAL OPERATING EXPENSES AMOUNTED TO MNOK 35.4
* Q2 NET NEGATIVE CASH FLOW FROM OPERATIONS WAS MNOK 33.0
* Q2 OPERATING LOSS NOK 35.4 MILLION VERSUS LOSS NOK 39.2
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE5S7wVz
Further company coverage: ULTI.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant